17Capital
17Capital LLP is a private equity firm established in 2008, headquartered in London, with an additional office in New York. The firm specializes in providing preferred equity financing for private equity portfolios, focusing on funds based in North America and Europe. It invests in both fund of funds and direct investments, targeting middle-market, later-stage, and mature companies across a diverse range of sectors, including oil and gas, healthcare, technology, and consumer goods. 17Capital offers flexible funding solutions to various investors, including private equity fund managers and limited partners, enabling them to increase investment capacity or unlock liquidity. The firm's investment range spans from €10 million to €500 million, with commitments typically lasting two to three years. It manages multiple funds backed by notable international institutions, including pension funds and sovereign wealth funds, and maintains a team with expertise in primary and secondary private equity markets as well as debt markets.
NewSpring Capital, founded in 1999 and based in Radnor, Pennsylvania, is a private equity firm that focuses on equity and debt investments across various sectors in the United States. The firm manages over $2 billion through multiple strategies, including growth equity, control buyouts, and mezzanine debt, and has invested in more than 150 companies. NewSpring prioritizes innovative franchise and multi-unit concepts within large and expanding markets, particularly in the TMT, communication, and networking sectors. The firm typically targets companies with a minimum EBITDA of $2 million and revenues ranging from $5 million to $25 million. By collaborating closely with management teams, NewSpring aims to facilitate growth and establish these businesses as market leaders, leveraging its extensive network of industry leaders and influencers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.